Skip to main content
Premium Trial:

Request an Annual Quote

Diversigen, Baylor Miraca Form Strategic Partnership

NEW YORK (GenomeWeb) – Diversigen announced today that it has formed a partnership with Baylor Miraca Genetics Laboratory (BMGL) to provide their customers with access to their respective targeted genomics and metabolomics services.

BMGL is a joint venture between the Baylor College of Medicine and Tokyo-based diagnostics firm Miraca Holdings that was established in 2014 to provide clinical genetics testing services. Diversigen, formerly Metanome, was established by Baylor venture capital arm BCM Technologies in 2013 to provide microbiome and metagenomics consulting, sequencing, and analysis services.

Under the terms of their arrangement, Diversigen and Baylor Miraca will provide their customers with access to the services of the other for studying host-microbiome relationships.

"Our pharmaceutical customers have expressed an interest in correlating microbiome data with specific host genetic traits to better understand the host-microbiome relationship as a factor in disease and in the search for more effective therapies," Diversigen President Cynthia Sheridan said in a statement. "This partnership with BMGL will allow us to provide broader services resulting in deeper insights into human health and disease."

"As we continue to transition from an academically centered genetic laboratory to a commercial organization focused on advancing patient health, access to the expert microbiome resources of the Diversigen team makes perfect sense," BMGL President and CEO Gary Huff added in the statement.

Specific terms of the deal were not disclosed.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.